Artificial Intelligence Chatbots in Allergy and Immunology Practice: Where Have We Been and Where Are We Going?

Artificial intelligence (AI) is rapidly becoming a valuable tool in healthcare, providing clinicians with a new AI lens perspective for patient care, diagnosis, and treatment. This article explores the potential applications, benefits, and challenges of AI chatbots in clinical settings, with a particular emphasis on ChatGPT 4.0 (OpenAI - Chat generative pretrained transformer 4.0), especially in the field of allergy and immunology. AI chatbots have shown considerable promise in various medical domains, including radiology and dermatology, by improving patient engagement, diagnostic accuracy, and personalized treatment plans. ChatGPT 4.0, developed by OpenAI, is good at understanding and replying to prompts in a way that makes sense. However, it is critical to address the potential biases, data privacy issues, ethical considerations, and the need for verification of AI-generated findings. When used responsibly, AI chatbots can significantly enhance clinical practice in allergy and immunology. However, there are still challenges in using this technology that require ongoing research and collaboration between AI developers and medical specialists. To this end, the ChatGPT 4.0 platform has the potential to enhance patient engagement, improve diagnostic accuracy, and provide personalized treatment plans in allergy and immunology practice. However, limitations and risks must be addressed to ensure their safe and effective use in clinical practice.